Has Steven Roh, MD received payments from drug or device companies?

Yes. Drug and device makers reported $67,171 in general payments to Steven Roh, MD across 217 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Roh, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Roh, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Roh, MD

Interventional Cardiology · Minneapolis, MNNPI 1750314795

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $58,900 of the $67,171 with a category attached, or 87.7%. Abbott accounts for 90.0% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $24,456, 5.2 times the $4,721 reported in 2019.

$67,171in general payments, 2019–2025

Across 217 payments — averaging $309.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$60K
Medtronic$4K
Boston Scientific$2K
Edwards Lifesciences$334
Inari Medical, Inc.$173
Shockwave Medical, Inc$164
plus $307 from 7 others

What the payments were for

Consulting fees$58,90088%
Travel & lodging$2,7064%
Food & beverage$5,5668%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	84	$60,481
Medtronic(2 entities)	91	$3,884
Boston Scientific	20	$1,827
Edwards Lifesciences	8	$334
Inari Medical, Inc.	1	$173
Shockwave Medical, Inc	2	$164
Abiomed	2	$149
Terumo Medical Corporation	4	$59
Cardiovascular Systems Inc.	1	$32
Bard Peripheral Vascular, Inc.	1	$22
Cardiva Medical, Inc.	1	$19
Angiodynamics, Inc.	1	$15
Biotronik Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

AMPLATZER AMULET$16,200
AMPLATZER Occluders$11,400
AMPLATZER TALISMAN$10,200
XIENCE SKYPOINT$7,400
JETi All In One Non-Sterile Kit$7,100
AMPLATZER$6,600
CoreValve Evolut$1,119
VersaCross Access Solution$1,053
MitraClip$783
COREVALVE EVOLUT R$457
WATCHMAN FLX$279
NAVITOR$201
FLOWTRIEVER CATHETER, S$173
CT THROMBECTOMY SYSTEM KIT$173
Telescope$158
SAPIEN 3 Ultra RESILIA$145
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$124
Impella$119
TYRX$111
SYNERGY$103

How this compares

$67,171 in reported general payments places this provider in the 85th percentile of 84 interventional cardiology providers in Minnesota.

See all interventional cardiology providers in Minnesota →

Medicare billing

Part B allowed, 2024

$79,408

Medicare patients

594

Services billed

1,249

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	178	$222,081
XareltoRivaroxaban	50	$69,464
Repatha SureclickEvolocumab	31	$47,253
EntrestoSacubitril/Valsartan	19	$23,878
Praluent PenAlirocumab	12	$11,026
Metoprolol Succinate	470	$8,625
Atorvastatin Calcium	315	$4,293
ClopidogrelClopidogrel Bisulfate	265	$4,037
Lisinopril	173	$2,457
Losartan Potassium	183	$2,421
Isosorbide Mononitrate ErIsosorbide Mononitrate	114	$2,419
Carvedilol	137	$2,231
Rosuvastatin Calcium	122	$2,064
Amlodipine Besylate	173	$2,035
Ezetimibe	91	$1,634

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Minneapolis

Emmanouil BrilakisMinneapolis$548K
Wesley PedersenMinneapolis$493K
Michael ManolesMinneapolis$201K
Jay TraverseMinneapolis$198K
Robert WilsonMinneapolis$176K
Yale WangMinneapolis$168K
Stefan BertogMinneapolis$64K
Konstantinos VoudrisMinneapolis$46K
Michael MooneyMinneapolis$25K
Alok SharmaMinneapolis$21K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →